CLINICAL_TRIALS trial_result · 2025-11-06

Clinical Trial Update: VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease [Phase 4]

View source ↗

Summary

Clinical trial update for VictORION-INCLUSION, a Phase 4 study evaluating inclisiran for cholesterol management in patients with atherosclerotic cardiovascular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Duke University | Conditions: Atherosclerotic Cardiovascular Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING